ClinicalTrials.Veeva

Menu

Strategy to Adapt Botulinum Toxin Doses in Dystonia

C

Central Hospital, Nancy, France

Status

Not yet enrolling

Conditions

Dystonia

Treatments

Drug: Botulinum toxin

Study type

Observational

Funder types

Other

Identifiers

NCT06386848
2023PI187

Details and patient eligibility

About

The study is designed to observ and collect the doses of botulinum toxin injected in dystonia in different centres to compare the initial dose and the dose recommended.

We we ll study the increase of the dose injected over the time, the side effects...

The hypothesis is that we inject smaller doses than we could regarding the recommandations

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients over 18 years old followed for dystonia and treated with botulinum toxin

Exclusion criteria

  • first dose of botulinum toxin not available

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems